Hemorrhagic Posterior Reversible Encephalopathy Syndrome in a Patient With Larynx Carcinoma
dc.authorid | Oğul, Hayri/0000-0001-5989-3729 | |
dc.contributor.author | Oğul, Hayri | |
dc.contributor.author | Kızıloğlu, Alper | |
dc.contributor.author | Oğul, Yasemin | |
dc.date.accessioned | 2023-07-26T11:57:26Z | |
dc.date.available | 2023-07-26T11:57:26Z | |
dc.date.issued | 2023 | |
dc.department | DÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyoloji Ana Bilim Dalı | en_US |
dc.description.abstract | Significance Statement Posterior reversible encephalopathy syndrome (PRES) is characterized by variable neurological findings such as headache, deterioration in mental condition, loss of consciousness and visual loss. The disease results with impairment of the cerebral blood flow autoregulation. Ondansetron, serotonin (5HT-3) receptor antagonist, may cause the haemorrhagic PRES. | en_US |
dc.identifier.doi | 10.1177/01455613221150121 | |
dc.identifier.issn | 0145-5613 | |
dc.identifier.issn | 1942-7522 | |
dc.identifier.pmid | 36592131 | en_US |
dc.identifier.scopus | 2-s2.0-85145678471 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.uri | https://doi.org/10.1177/01455613221150121 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/13180 | |
dc.identifier.wos | WOS:000906850300001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.institutionauthor | Oğul, Hayri | |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.relation.ispartof | Ent-Ear Nose & Throat Journal | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | $2023V1Guncelleme$ | en_US |
dc.subject | Haemorrhagic Posterior Reversible Encephalopathy Syndrome; Ondensatron; Magnetic Resonance Imaging; Susceptibility Weighted Imaging | en_US |
dc.subject | Spectrum | en_US |
dc.title | Hemorrhagic Posterior Reversible Encephalopathy Syndrome in a Patient With Larynx Carcinoma | en_US |
dc.type | Editorial | en_US |